Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill J.C. Suarez Montero; A.C. Caballero Gonzalez; L. Martín Aguilar; J. Mancebo Cortés;

Analgosedation and delirium practices in critically ill patients in the Pan-American and Iberian setting, and factors associated with oversedation after the COVID-19 pandemic: Results from the PANDEMIC study Carola Giménez-Esparza Vich; Felipe Martínez; Daniela Olmos Kutscherauer; Daniel Molano; Maria del Carmen Gallardo; Enrique Mario Olivares-Durán; Jesús Caballero; Rosa Reina; Manuela García Sánchez; Federico C. Carini;

Short- and long-term mortality in critically ill patients with solid cancer. The Vall d¿Hebron Intensive Care Unit-Vall d¿Hebron Institute of Oncology Cohort: a retrospective study Cándido Díaz-Lagares; Alejandra García-Roche; Andrés Pacheco; Javier Ros; Erika P. Plata-Menchaca; Adaia Albasanz; David Pérez; Nadia Saoudi; Isabel Ruiz-Camps; Elena Élez; Ricard Ferrer;